• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Skyepharma PLC

+ Add to Watchlist

SKYEY:US

4.1500 USD 0.0100 0.24%

As of 20:10:00 ET on 08/20/2014.

Snapshot for Skyepharma PLC (SKYEY)

Open: 4.2000 Day's Range: 4.1500 - 4.2000 Volume: 1,867
Previous Close: 4.1600 52wk Range: 1.2500 - 4.5300 1-Yr Rtn: +229.37%

Stock Chart for SKYEY

No chart data available.
  • SKYEY:US 4.1500
  • 1D
  • 1M
  • 1Y
4.1600
Interactive SKYEY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SKYEY

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 14.8063
Relative P/E vs. SPX -
Earnings Per Share (GBP) (ttm) -
Est. EPS (GBP) (12/2014) 0.1690
Est. PEG Ratio -
Market Cap (M USD) 434.97
Shares Outstanding (M) 104.81
30 Day Average Volume 607
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 1.7534
Dividend Ex-Date 11/02/2005
5 Year Dividend Growth -
Next Earnings Announcement 08/21/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SKYEY

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for SKYEY

SkyePharma plc operates a group of companies that research, develop, manufacture and market prescription pharmaceutical products. The Group's products are available in topical, oral, injectable and inhalation form.

Peter William GrantChief Executive OfficerAndrew DerodraChief Financial Officer
John MurphySecretary/General Counsel
More Company Profile & Key Executives for SKYEY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil